Home › Browse › Award
Award
GB
FTS
Multi-Drug Resistant TB (MDR-TB) Clinical Advice Service
NHS England
- Stage
-
Awardthe latest stage the buyer has published
- Buyer
- Supplier
-
British Thoracic Societytaken from the supplier contact on the notice
- Value
-
£50KVAT basis not stated · GBP
- Awarded
-
21 Jul 2026the signed contract date on the notice
- End date
-
For subscribers only
- First published
-
21 Jul 2026last seen 21 Jul 2026
What the buyer published
The MDR-TB Clinical Advice Service provides expert, consistent and safe advice to clinicians treating MDR-TB. The Clinical Advice Service examines and ratifies local MDR-TB centre requests for the use of the MDR-TB agents, Bedaquiline and Delamanid. Due to delays arising from administrative and operational circumstances, NHS England awarded this contract to British Thoracic Society commencing 01.04.2026